Impact of prior antiplatelet therapy on risk of embolism in infective endocarditis - sprookjes - yvandenbroek - TriplyDB

Impact of prior antiplatelet therapy on risk of embolism in infective endocarditis

Impact of prior antiplatelet therapy on risk of embolism in infective endocarditis

http://www.wikidata.org/entity/Q28222033

about

Infective endocarditis epidemiology over five decades: a systematic review Effectiveness of Thrombolytic Therapy in Acute Embolic Stroke due to Infective Endocarditis Role of vegetation-associated protease activity in valve destruction in human infective endocarditis.Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the Eu Modifiers of symptomatic embolic risk in infective endocarditis.Management of neurological complications of infective endocarditis in ICU patients Association between acetylsalicylic acid and the risk of dialysis-related infections or septicemia among incident hemodialysis patients: a nested case-control study.Aspirin plus ticlopidine prevented experimental endocarditis due to Enterococcus faecalis and Streptococcus gallolyticus.Higher platelet reactivity and platelet-monocyte complex formation in Gram-positive sepsis compared to Gram-negative sepsis.Pediatric endocarditis and stroke: a single-center retrospective review of seven cases Anti-thrombotic therapy in infective endocarditis.Manifold beneficial effects of acetyl salicylic acid and nonsteroidal anti-inflammatory drugs on sepsis.Current trends in the management of cardiac implantable electronic device (CIED) infections.Impact of antiplatelet therapy on clinical manifestations and outcomes of cardiovascular infections.Prosthetic Aortic Valve Endocarditis with Left Main Coronary Artery Embolism: A Case Report and Review of the Literature.Bacterial Endocarditis and Cerebrovascular Disease.2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the Eur Coagulation and infective endocarditis: sooner or later.Haemophilus parainfluenzae prosthetic valve endocarditis complicated by septic emboli to brain.Platelet reactivity in diabetic patients with invasive liver abscess syndrome An Association Between Aspirin Use in Human Cases of Infective Endocarditis and Reduced Systemic Embolism Is Shown in Meta-analysis of Observational Studies

P2860

Q27024815-B5880155-2D7B-4293-8CDB-36AE22A0C76E Q34078100-52A87196-E6BA-4533-9C9F-96B6530FEB19 Q34429820-48784726-0648-42D6-ADEF-B56AAEFB02D3 Q34611253-1139B76F-EAD1-4FC5-A5EC-1E06F15A3EEA Q35460905-2B7749F3-C2B4-48ED-AC4D-59A0053F2DBF Q35574047-B0C4C014-11FE-47D1-9DDE-95DDD911EF6C Q35717207-96039C15-C988-4DE3-BF5B-AFCCA14726D8 Q36226465-52724BC3-4876-4BB5-AEFE-2C35ACF4F661 Q36235371-747F0B72-8668-47E0-A2FF-1F31D732A324 Q36693498-45D78FE3-BDB0-44AD-9770-C5C75E19F230 Q37935785-A74CEF6C-FE44-427D-8479-EA2426DC60FD Q38005318-24F21732-088D-4CCB-8BE9-585D962378D3 Q38022551-7FA1E15F-E10C-4161-89EB-EE6457671D0E Q38113160-FEBADE51-45CA-4443-AA6D-3396A5617D2B Q38921510-B0F0CB2F-9A6D-4A54-9356-3A0890E93905 Q38999256-7A728DCA-6884-4B0B-A1FC-65DAC2D7FC6B Q41026009-EECE2D26-410B-4EB6-9CDF-0C93E80544FB Q41191097-D539B408-F934-40B8-8344-8F52C1C0A38F Q42765167-A5F754FD-2532-4AEF-AFE7-9CDEF6315BAC Q57817171-F29F06B7-EB7E-4921-B6F5-87D91FF706AE Q58847327-B9DE190B-87BD-4BBB-A63D-730DD05D2F36

P2860

Impact of prior antiplatelet therapy on risk of embolism in infective endocarditis

http://www.wikidata.org/entity/Q28222033

description

2007 nî lūn-bûn

@nan

2007 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Impact of prior antiplatelet therapy on risk of embolism in infective endocarditis

@ast

Impact of prior antiplatelet therapy on risk of embolism in infective endocarditis

@en

Impact of prior antiplatelet therapy on risk of embolism in infective endocarditis

@nl

type

label

Impact of prior antiplatelet therapy on risk of embolism in infective endocarditis

@ast

Impact of prior antiplatelet therapy on risk of embolism in infective endocarditis

@en

Impact of prior antiplatelet therapy on risk of embolism in infective endocarditis

@nl

prefLabel

Impact of prior antiplatelet therapy on risk of embolism in infective endocarditis

@ast

Impact of prior antiplatelet therapy on risk of embolism in infective endocarditis

@en

Impact of prior antiplatelet therapy on risk of embolism in infective endocarditis

@nl

P1433

Q28222033-F6EA3612-BF85-4062-893E-FDA14BDA7069

P1476

Q28222033-8F00F1F5-D979-4955-9702-75884D734926

P2093

Q28222033-367423C5-C48E-4903-AA7C-6750587879A3

Q28222033-3D875BB6-AEA5-4357-9BA1-9D963FE4E58D

Q28222033-9447A52E-642F-4223-BFB5-4EC1C0C6D7D0

Q28222033-A0D9660A-078C-437C-AF0B-E1A57C76DA78

Q28222033-A97003C9-C63E-4C33-804B-1D495F70D60C

Q28222033-B0E8D48B-9A00-4B5A-9E46-5560C8AE6524

Q28222033-C4DA691E-F870-48D1-8EDD-0A0DC227B2F1

Q28222033-D527C95E-0C99-404A-8CFC-AE08973B3CC7

Q28222033-E01CC06A-682F-40BA-82E4-536F2E7D53F1

Q28222033-EF66ADB4-0E92-4D1D-AABA-18747B63FA6D

P304

Q28222033-3011C6C3-561E-4B4F-B8E9-BCCE07CBEB5F

P31

Q28222033-EC4BC131-29E0-4B8C-81C3-8B9C45DCA599

P3181

Q28222033-5E717D3F-18C1-4A35-8243-4071E5464498

P356

Q28222033-530DD5C2-BCA6-4512-B761-ACA1E7F124CD

P407

Q28222033-68EB0DDC-6064-4DE0-B571-4B85B21EE2C1

P433

Q28222033-50F4161D-755A-4891-94CD-29625D6C243E

P478

Q28222033-6EE46528-65ED-48A1-A2DD-C1BE72A751CE

P577

Q28222033-43DD12C3-39B1-43D0-91CA-C7A0BABCD724

P5875

Q28222033-BA5B9AF8-F6DC-4C1D-8C2C-484EC05180C1

P698

Q28222033-E1F218B9-F9FE-4628-BB6F-92D93D541CFF

P3181

P356

P1433

Clinical Infectious Diseases

P1476

Impact of prior antiplatelet therapy on risk of embolism in infective endocarditis

@en

P2093

Christopher Haddad

http://www.w3.org/2001/XMLSchema#string

Imad M Tleyjeh

http://www.w3.org/2001/XMLSchema#string

James M Steckelberg

http://www.w3.org/2001/XMLSchema#string

Krishnaswamy Chandrasekaran

http://www.w3.org/2001/XMLSchema#string

Larry M Baddour

http://www.w3.org/2001/XMLSchema#string

Masud H Khandaker

http://www.w3.org/2001/XMLSchema#string

Nagesh S Anavekar

http://www.w3.org/2001/XMLSchema#string

Nandan S Anavekar

http://www.w3.org/2001/XMLSchema#string

Walter R Wilson

http://www.w3.org/2001/XMLSchema#string

Zaur Mirzoyev

http://www.w3.org/2001/XMLSchema#string

P304

1180-6

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1343188

http://www.w3.org/2001/XMLSchema#string

P356

10.1086/513197

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

44

http://www.w3.org/2001/XMLSchema#string

P577

2007-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6415005

http://www.w3.org/2001/XMLSchema#string

P698

17407036

http://www.w3.org/2001/XMLSchema#string